Dalata Hotel Group Rejects Pandox Consortium Offer

Dalata Hotel Group PLC has declined a non-binding proposal from the Pandox Consortium for a potential cash offer. The offer, valued at 605 cents per share, was deemed by Dalata's Board as significantly underestimating the company's value and prospects.

The proposal was reviewed within the context of Dalata's ongoing Formal Sales Process (FSP) and strategic review initiated in March 2025, aimed at optimizing shareholder value. Dalata confirmed ongoing discussions with several parties participating in the FSP, while Pandox has chosen not to participate under current terms.

The Pandox Consortium must decide by July 15, 2025, whether to proceed with a firm offer. Dalata remains in an offer period, and shareholders are advised against taking action regarding the Pandox proposal.